Using public clinical data, the Kaplan-Meier survival analysis found that ZBTB46, one of these 11 genes, is associated with a higher survival rate among lung cancer patients than those with low levels, implying that ZBTB46 expression may be associated with lung cancer protection. The gene discussed is ZBTB46; the disease is lung carcinoma.